Sales decline 72.58% to Rs 35.77 crore
Net Loss of Sharon Bio-Medicine reported to Rs 153.73 crore in the quarter ended March 2016 as against net loss of Rs 56.43 crore during the previous quarter ended March 2015. Sales declined 72.58% to Rs 35.77 crore in the quarter ended March 2016 as against Rs 130.44 crore during the previous quarter ended March 2015.For the full year,net loss reported to Rs 300.27 crore in the year ended March 2016 as against net loss of Rs 233.90 crore during the previous year ended June 2015. Sales declined 69.77% to Rs 253.45 crore in the year ended March 2016 as against Rs 838.46 crore during the previous year ended June 2015.
ParticularsQuarter EndedYear EndedMar. 2016Mar. 2015% Var.Mar. 2016Jun. 2015% Var.Sales35.77130.44 -73 253.45838.46 -70 OPM %-392.23-1.96 --53.37-4.09 - PBDT-176.06-15.66 -1024 -204.31-125.35 -63 PBT-181.07-23.35 -675 -219.32-144.61 -52 NP-153.73-56.43 -172 -300.27-233.90 -28
Powered by Capital Market - Live News
